| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.05B | 25.26B | 27.57B | 25.44B | 23.89B | 25.02B |
| Gross Profit | 8.31B | 8.90B | 9.80B | 10.26B | 12.44B | 15.71B |
| EBITDA | 7.37B | 8.73B | 12.83B | 7.11B | 9.80B | 13.09B |
| Net Income | 6.03B | 6.30B | 9.26B | 9.24B | 13.20B | 10.19B |
Balance Sheet | ||||||
| Total Assets | 532.57B | 531.24B | 542.55B | 529.79B | 550.30B | 461.09B |
| Cash, Cash Equivalents and Short-Term Investments | 17.65B | 18.77B | 22.11B | 11.74B | 11.34B | 6.13B |
| Total Debt | 81.47B | 154.22B | 161.69B | 150.09B | 159.48B | 89.76B |
| Total Liabilities | 193.84B | 190.66B | 198.45B | 184.64B | 198.13B | 128.90B |
| Stockholders Equity | 320.14B | 322.15B | 326.54B | 327.95B | 335.02B | 327.61B |
Cash Flow | ||||||
| Free Cash Flow | 5.92B | 15.30B | 14.46B | 7.95B | -54.16B | 4.51B |
| Operating Cash Flow | 8.78B | 15.30B | 14.46B | 11.13B | 685.00M | 7.07B |
| Investing Cash Flow | -9.30B | -1.87B | 16.00M | 12.15B | -50.04B | -974.00M |
| Financing Cash Flow | -2.37B | -21.20B | -5.42B | -21.30B | 52.05B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$145.14B | 24.10 | 1.76% | 6.20% | -19.91% | -6.92% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$21.47B | 7.71 | 1.39% | 5.62% | -9.78% | -29.50% | |
61 Neutral | HK$5.26B | 6.75 | 6.10% | 5.22% | 590.98% | 538.64% | |
59 Neutral | HK$12.86B | -6.82 | -3.14% | 5.93% | 1.37% | -157.43% | |
45 Neutral | HK$1.74B | -0.83 | -3.56% | ― | 72.75% | 25.44% | |
40 Underperform | HK$21.52B | -1.70 | -9.54% | ― | -40.92% | -42.67% |